| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 356.38M | 534.05M | 513.51M | 753.31M | 601.57M |
| Gross Profit | 90.62M | 287.02M | 286.64M | 268.48M | 358.97M |
| EBITDA | 163.51M | 208.33M | 229.43M | 207.20M | 287.34M |
| Net Income | 37.34M | 59.90M | 70.84M | 51.93M | 103.83M |
Balance Sheet | |||||
| Total Assets | 1.47B | 1.91B | 1.73B | 1.78B | 1.86B |
| Cash, Cash Equivalents and Short-Term Investments | 301.77M | 114.46M | 130.72M | 89.43M | 76.09M |
| Total Debt | 414.57M | 832.77M | 828.34M | 852.53M | 810.90M |
| Total Liabilities | 561.34M | 1.04B | 913.52M | 1.03B | 1.14B |
| Stockholders Equity | 907.65M | 876.28M | 816.13M | 744.88M | 718.87M |
Cash Flow | |||||
| Free Cash Flow | 75.91M | -14.54M | 167.00M | 106.74M | 151.14M |
| Operating Cash Flow | 134.87M | 174.02M | 172.57M | 118.67M | 169.07M |
| Investing Cash Flow | 98.56M | -187.29M | -4.95M | -11.34M | -17.57M |
| Financing Cash Flow | -46.25M | -2.99M | -126.34M | -93.98M | -207.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$193.87M | 2.72 | 11.72% | ― | -40.01% | -63.23% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | HK$481.53M | 14.01 | 4.00% | 1.05% | -30.94% | -35.73% | |
57 Neutral | HK$498.73M | -6.35 | 0.17% | 3.70% | 5.61% | 18.18% | |
50 Neutral | HK$1.49B | -0.32 | -35.49% | ― | -4.27% | -174.28% | |
46 Neutral | HK$121.98M | -0.09 | ― | ― | -21.67% | -18.64% | |
40 Underperform | HK$419.00M | -1.02 | -16.15% | ― | ― | ― |